Related Experiment Videos
Biocompatibility of extracorporeal immunoadsorption systems
Transfusion Science
|December 10, 1989
Summary
Extracorporeal immunoadsorption, a haemapheresis technique, shows promise despite challenges. Advances in molecular diagnostics may enhance future applications by improving specificity and reducing side effects.
Area of Science:
- Nephrology
- Immunology
- Biotechnology
Background:
- Extracorporeal immunoadsorption has evolved significantly since its inception in 1969.
- It is emerging as a valuable haemapheresis technique, offering potential advantages that surpass current technical and economic limitations.
Purpose of the Study:
- To review the current state and future prospects of extracorporeal immunoadsorption.
- To highlight ongoing clinical investigations and potential advancements in the field.
Main Methods:
- Discussion of three primary immunoadsorption techniques currently under clinical investigation: Staphylococcus Protein-A (SpA) based, antibody-mediated (therapeutic affinity chromatography), and hydrophobic interaction-based immunoglobulin adsorption.
- Exploration of the role of molecular-biologic diagnostic procedures, such as monoclonal antibodies, in advancing the technology.
Main Results:
- While SpA and amino acid-based techniques require further elucidation of binding mechanisms and capacity, antibody-mediated systems face challenges due to incomplete knowledge of pathogenic substrates.
- The immunomodulatory effects of blood-surface interactions are a key area of biocompatibility research.
Conclusions:
- Extracorporeal immunoadsorption holds significant therapeutic potential, with ongoing research addressing current limitations.
- Advancements in diagnostic specificity and rigorous biocompatibility assessments are crucial for preventing adverse effects and optimizing clinical application.